Metabolic Comorbidities in Patients with Psoriasis: Differences Between Those With and Without Psoriatic Arthritis in a Caribbean Cohort

Read full text Summarise with VIRAT
Authors: Vianka De La Cruz, Pablo Camilo, Alvaro Taveras-Franco, Samantha Pelegrín, Steffanie Camilo-Tertulien, Rosa Tertulien
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Psoriasis is a chronic immune-mediated inflammatory disease associated with systemic comorbidities. Psoriatic arthritis (PsA) represents a more extensive disease phenotype and may be associated with a higher burden of metabolic comorbidities. Objective: To compare the prevalence of metabolic comorbidities between patients with psoriasis with and without psoriatic arthritis. Methods: A retrospective observational study was conducted including 548 patients with clinically confirmed psoriasis from multiple dermatologic centers in the Dominican Republic. Patients were categorized according to the presence or absence of psoriatic arthritis. Sociodemographic and clinical data were obtained from medical records. Metabolic comorbidities analyzed included obesity, hypertension, diabetes mellitus, and smoking status. Comparisons between groups were performed using chi-square tests. Variables with statistical significance in bivariate analysis were further evaluated using multivariable logistic regression to identify factors independently associated with psoriatic arthritis. Statistical significance was defined as p < 0.05. Results: A total of 548 patients were included, of whom 18.6% had psoriatic arthritis. Patients with PsA demonstrated a higher prevalence of obesity (41.2% vs 29.6%, p = 0.009), hypertension (45.7% vs 33.8%, p = 0.014), and diabetes mellitus (30.4% vs 21.7%, p = 0.038) compared with patients without PsA. Smoking was more frequent in the PsA group (27.5% vs 20.9%), although this difference did not reach statistical significance (p = 0.081). In multivariable logistic regression analysis, obesity (OR 1.84, 95% CI 1.18–2.87, p = 0.006) and hypertension (OR 1.52, 95% CI 1.01–2.29, p = 0.044) remained independently associated with psoriatic arthritis, while diabetes mellitus and smoking were not independently associated after adjustment. Conclusion: Patients with psoriatic arthritis exhibit a higher prevalence of metabolic comorbidities compared with those with psoriasis alone. These findings support the concept of psoriatic arthritis as a more systemic disease phenotype and highlight the importance of comprehensive metabolic evaluation in patients with psoriatic disease.

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Psoriasis: Treatment and Pathogenesis Osteomyelitis and Bone Disorders Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
29 March 2026
Language
EN